Your cart is currently empty!
JARDYMET TAB 12.5/500
₨ 27
Jardiamet 12.5mg/500mg tablets are a combination medication containing empagliflozin and metformin. This medication is used as an adjunct therapy for managing type 2 diabetes and reducing cardiovascular risk in adults with established cardiovascular disease.
14 in stock
Description
Jardiamet 12.5mg/500mg Tablets: Key InformationIntroduction Jardiamet 12.5mg/500mg tablets are a combination medication containing empagliflozin and metformin. This medication is used as an adjunct therapy for managing type 2 diabetes and reducing cardiovascular risk in adults with established cardiovascular disease.
Mechanism of Action
Empagliflozin Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It works by increasing the removal of sugar through the kidneys, preventing glucose reabsorption, and promoting glucose excretion in the urine. This helps lower blood sugar levels.
Metformin Metformin is a biguanide that improves insulin utilization. It decreases glucose production in the liver and increases the sensitivity of muscle cells to insulin, allowing for better glucose uptake and utilization, thereby lowering blood sugar levels.
Benefits of Jardiamet Tablets The combination of empagliflozin and metformin in Jardiamet tablets offers several benefits:
Effective Glycemic Control: The dual action of empagliflozin and metformin helps maintain optimal blood sugar levels.
Cardiovascular Risk Reduction: Empagliflozin has been shown to reduce the risk of cardiovascular events in individuals with type 2 diabetes and established cardiovascular disease.
Precautions and Warnings
Pregnancy It is advised to avoid Jardiamet tablets during pregnancy. The effects of this medication on an unborn child are not well-studied, and it is important to consult a healthcare provider for alternative treatments.
Driving and Operating Machinery Patients should be aware that Jardiamet tablets may affect their ability to drive or operate machinery due to the potential for hypoglycemia (low blood sugar), which can impair cognitive and motor functions.
Conclusion Jardiamet 12.5mg/500mg tablets are an effective combination therapy for managing type 2 diabetes and reducing cardiovascular risks in adults with established cardiovascular disease. By combining empagliflozin and metformin, this medication helps control blood sugar levels and offers cardiovascular benefits. Always consult with a healthcare provider for personalized medical guidance and follow medical advice regarding its use during pregnancy and activities requiring full alertness.